🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 55287L101
Business: MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. MBX Biosciences is advancing a pipeline of novel candidates for endocrine and metabolic disorders with clinically validated targets, established endpoints for regulatory approval, significant unmet medical needs and large potential market opportunities.
Company Contact
- CEO
- P. Kent Hawryluk
- CFO
- Richard Bartram
- Headquarters
- 11711 N. Meridian Street, Suite 300, Carmel, IN 46032
- Phone
- 317-659-0200
- Investor Relations
- Jim DeNike, MBX Biosciences · 917-734-7387 · jdenike@mbxbio.com